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Abstract
Many breastfeeding women require and regularly take medicines, especially those available over-the-counter, and
the safe use of these is dependent on the advice provided by health professionals such as general practitioners
and pharmacists. The primary aim of this review therefore, was to investigate the literature relating to health
professionals’ and women’s knowledge, attitudes and practices towards medication use and safety in breastfeeding.
The limited literature that was uncovered identified that general practitioners and pharmacists have poor
knowledge, but positive attitudes, and variable practices that are mostly guided by personal experience. They tend
to make decisions about the use of a medicine whilst breastfeeding based on the potential ‘risk’ that it poses to
the infant in terms of possible adverse reactions, rather than its ‘compatibility’ with breast milk. The decision-
making process between health professionals and women is usually not a negotiated process, and women are
often asked to stop breastfeeding whilst taking a medicine. Women, in turn, are left dissatisfied with the advice
received, many choosing not to initiate therapy or not to continue breastfeeding. Some directions for future
research have been suggested to address the issues identified in this critical area. This review is important from a
societal perspective because many breastfeeding women require and regularly take medications, especially those
available without prescription, and the safe use of these is dependent on the advice provided by health
professionals, which is ultimately influenced by their knowledge, attitudes and practices. However, there is an
absence of high quality evidence from randomised controlled trials on the safety of medications taken during
breastfeeding, which naturally would hinder health professionals from appropriately advising women. It is equally
important to know about women’s experiences of advice received from health professionals, and whether there is
consistency between recommendations made across resources on medication safety in breastfeeding, in order to
gain a full understanding of the issues prevalent in this area of practice.
Review
In July-October 2010, keywords (e.g. health profes-
sionals, doctors, nurses, pharmacists, lactation, breast-
feeding, medication, medicine, knowledge, attitude/s,
practice/s, behaviour/s) were used, either separately or
in combination, to search databases such as Ovid, Pub
Med, International Pharmaceutical Abstracts and Google
Scholar. The search was restricted to articles published
on primary research data, in English, and from 1990
onwards. The same keywords were used to search rele-
vant journals such as BMC Women’sH e a l t h ,M e d i c a l
Journal of Australia, International Breastfeeding Journal
and Journal of Human Lactation. The reference lists of
relevant articles retrieved from these journals were
hand-searched for additional studies.
Thirty-one publications were found that were assessed
for relevance to the topic area, 15 of which were not
within the scope of this review - 13 that did not investi-
gate health professionals’ breastfeeding knowledge, atti-
tudes or practices in the context of prescribing
medication for women [1-13]; one that did not deter-
mine women’s experiences with receiving advice from
health professionals on medication use and safety in
breastfeeding [14]; and another that was a review of
primary research data [15].
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critiqued [16-32]. These reported on studies that mostly
used cross-sectional designs; generally had low response
rates (RRs); and were undertaken in Australia, Canada,
Israel, The Netherlands, USA and United Kingdom
(UK), and whose findings therefore cannot be general-
ised to other settings.
Table 1 details 11 studies - seven that have been con-
ducted with health professionals only [17,18,21,26,
28,31,32] (where references 17-18 and 21 concern the
same study); two with pharmacists, general practitioners
(GPs) and breastfeeding women together [22,23] (these
concern the same study); another with pharmacists and
breastfeeding women [25]; and one with endocrinolo-
gists, family physicians and women [30]. In the four stu-
dies that involved health professionals and women
[22,23,25,30], only the findings on the health profes-
sionals have been detailed, and those associated with the
women are shown in Table 2.
Table 2 also highlights nine studies - five with breast-
feeding women alone [19,20,24,27,29]; two with breast-
feeding women, pharmacists and GPs together [22,23]
(again, these concern the same study); another with
breastfeeding women and pharmacists [25]; and one with
women, endocrinologists and family physicians [30].
Table 3 includes information on the only study that
has been undertaken to determine the recommendations
made within resources on medication safety in breast-
feeding [16].
A synthesis of the evidence from these studies is pre-
sented below. Individual studies are mentioned, where
appropriate, to highlight key points or compare and
contrast findings between studies.
Health professionals
No studies were uncovered between 1990-97 on health
professionals’ knowledge, attitudes and practices towards
medication use and safety in lactation. Most of the stu-
dies conducted from 1998-2010 are on GPs, also known
as family physicians [17,18,21-23,30,31], with no repre-
sentation from maternal and child health community
nurses, who have an important role in this area given
that they interact frequently with mothers in the post-
partum and postnatal periods, but at the same time do
not have prescribing rights or formal knowledge of
pharmacology or medications.
While some GPs have been found to be supportive of
medication use during breastfeeding [18,21,30], others
have unnecessarily advised women to cease therapy
whilst breastfeeding [18,21], or to stop breastfeeding
temporarily or permanently [22,23] as the risks asso-
ciated with breastfeeding cessation were viewed to out-
weigh the benefits and risks of medication use [23]. A
high percentage have even advised against breastfeeding
initiation [30]. This latter and highly unfavourable situa-
tion is occurring even when there is adequate safety
data to support the use of several medications whilst
breastfeeding, ranging from those used to treat acute
and minor ailments (e.g. ibuprofen for pain), to those
prescribed for chronic and debilitating conditions (e.g.
fluoxetine and sertraline for depression, propylthiouracil
[PTU] for hyperthyroidism) [23,30,33].
Indeed, for medications such as antidepressants, the
GP’s decision to prescribe them should be arrived at by
conducting a risk versus benefit assessment [23,33],
“taking into account factors such as the maturity of the
infant, the frequency of feeds and the volume of milk
consumed” [23]. The woman’s preferences for treatment
must also be considered and are equally important;
however, only 4% (23/590) of GPs who responded to the
survey by Jones and Brown indicated that the woman
would be involved in making an informed choice [22].
In the study by Lee et al, women who received physi-
cian advice in favour of breastfeeding were more likely
to breastfeed during PTU therapy than formula feed
(relative risk: 5, 95% confidence interval: 1-23) [30].
Around 25% of endocrinologists in the same study who
responded to case vignettes presented in a postal survey
advised against breastfeeding during PTU treatment, but
also said they would change their recommendation if
the woman expressed the desire to breastfeed. Neverthe-
less, where a mutual decision to use medication is made,
the breastfed infant should be monitored for adverse
effects (e.g. sedation, failure to thrive) and if they are
suspected, blood samples from the woman and the
infant may be taken for laboratory analysis [33].
Some GPs have even been reported to use pregnancy
drug categories for breastfeeding [18], which means that
their recommendations to either continue or stop
breastfeeding may be incorrect. However, GPs (and
other health professionals such as pharmacists) have
acknowledged that it is difficult to stop breastfeeding
abruptly despite their recommendations for women to
do so [22,23].
It appears that incorrect recommendations are being
made mainly because of poor self-reported [28] or
actual [30-32] knowledge, which has been found to be
influenced by frequency of contact with women [31,32],
as well as health professionals’ personal or partner
experience of breastfeeding their own children, although
the latter may place them in a better position to handle
breastfeeding and medication related problems [22,23].
For example, in a mail survey of 265 pharmacists practi-
cing in community pharmacies in Nebraska, United
States of America (USA), it was found that for treating
insomnia, 10% of the respondents recommended
diphenhydramine (contraindicated in lactation), guaiphe-
nesin (no data on safety) and dextromethorphan (might
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Publication details and country Study design, participants and
setting
Study aims Key findings
[25] Merlob P, Bracha S, Kaplan B.
Drug use in pregnancy and breast
feeding: the role of the pharmacist.
The International Journal of Risk and
Safety in Medicine 1998, 11: 45-7.
Israel.
66 pharmacists working at Rabin
Medical Center and from private
pharmacies were interviewed (via
telephone or personal visit). No
details were provided on how
participants were selected for the
study and how their details were
obtained.
To examine the rate of pharmacist
counselling of women who use
medications during pregnancy and/
or breastfeeding.
Only 9% (6/66) of pharmacists said they made a practice of asking women two
basic questions: “Are you pregnant or nursing?” and “Did you receive an
explanation (of the drug(s) in question) from your physician? In no case did the
pharmacist offer information at their own initiative.
[22] Jones W, Brown D.
‡ The
pharmacist’s contribution to primary
care support for lactating mothers
requiring medication. Journal of
Social and Administrative Pharmacy
2000, 17: 88-98.
England.
Mail questionnaire sent to 939 GPs
and 948 community pharmacists in
the South and West NHS Executive
region of Hampshire, Wiltshire,
Dorset and the Isle of Wight. GPs
were selected by systematically
sampling every fifth name from lists
supplied by the local health
commission, and pharmacists were
identified from information supplied
by the Royal Pharmaceutical Society
of Great Britain.
To investigate the knowledge and
attitudes of GPs and community
pharmacists to the safety of infants
exposed to medications via breast
milk and the importance of
continuing breastfeeding.
RR (GPs) = 63% (590/939) and RR (pharmacists) = 68% (641/948). 80% (473/590) of
GPs had personal/partner experience of breastfeeding, with the majority (83%,
490/590) agreeing/strongly agreeing with the statement that “Breastfeeding is a
health promotion issue”. Most pharmacists (82%, 523/641) also agreed/strongly
agreed with this statement and many (66%, 422/641) had personal/partner
experience of breastfeeding. The majority of GPs (93%, 551/590) said that they
would always ask a woman with a baby how she was feeding her child before
prescribing medications for her, with significantly fewer pharmacists (318/641,
50%) doing the same. Only 22% (129/590) of GPs said that they would always ask
this question to a woman with a toddler. The importance of the breastfeeding
relationship for women beyond 6 months was similarly underestimated by
pharmacists. Most pharmacists (76%, 486/641) also said that GPs never contacted
them for information on medication use and safety in breastfeeding, in contrast
to some GPs who said that they would contact the pharmacist (15%), a drug
information centre (9%) or the manufacturer (7%). GPs felt it was quite important
to inform a woman of potential side effects of a medication if she continues to
breastfeed whilst taking it, and they often did this. Pharmacists, on the other
hand, while feeling that it was very important to inform a breastfeeding woman,
didn’t often do so, despite the fact that many reported being asked by women
about medication safety (pertaining to, e.g. tranqulisers, hypnotics, oral
contraceptives, cough/cold remedies, laxatives) from once a week (46%) to once
a month (40%). 9 pharmacists stated that it was the woman’s responsibility to
inform them that she was breastfeeding and to initiate the query. 50% of GPs
and 43% of pharmacists rated the quality of information available on medication
use and safety in breastfeeding as acceptable, compared to 22% of GPs and 28%
of pharmacists who thought it was of insufficient quality. Interprofessional
workshops on the topic were appreciated more by pharmacists (72%, 459/641)
than GPs (43%, 255/590). Pharmacists were also found to be more interested
(83%) in undertaking a distance learning package in this area than GPs (45%).
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(Continued)
[30] Lee A, Moretti ME, Collantes A,
Chong, D, Mazzotta P, Koren G,
Merchant SS, Ito S. Choice of
breastfeeding and physicians’ advice:
A cohort study of women receiving
propylthiouracil. Pediatrics 2000, 106
(1):27-30.
Canada.
Mail questionnaire sent in 1997 to
all Ontario endocrinologists (92) and
randomly selected family physicians
(300) listed in the Canadian Medical
Directory. Two case vignettes were
presented in the survey - 1) a
breastfeeding woman requires 300
mg/day of propylthiouracil (PTU)
and has no preference for a feeding
method; and 2) a woman on the
same dose wishes to breastfeed.
Participants were asked to state if
they would recommend
breastfeeding, and whether they
had had to provide such advice in
the past year. If the respondent was
unsure of their recommendation,
they were asked to select from a list
which information sources they
would consult to obtain an answer.
To examine physicians’ attitude
toward PTU therapy during
breastfeeding.
RR = 72% (endocrinologists) and 38% (family physicians). 47% of endocrinologists,
compared with only 1% of family physicians, had given advice within the last
year on the use and safety of PTU during breastfeeding. Of all physicians who
indicated that they would not recommend breastfeeding in case 1, 2 or both,
81% listed drug amount found in the breast milk as a primary reason for not
recommending breastfeeding. 8 family physicians and 5 endocrinologists who
were unsure of the compatibility of PTU with breastfeeding provided information
sources they would consult. Reference books (66%) were favoured amongst
family physicians, followed by colleagues (60%) and other sources (57.5%).
Literature searches were chosen by all endocrinologists, followed by reference
books and colleagues with or without an additional source. 1 in 4
endocrinologists who were found to be against breastfeeding during PTU
treatment reported that they would change their advice to being in favour of
breastfeeding if the woman wanted to breastfeed.
[28] Schrempp S, Ryan-Haddad A,
Gait KA. Pharmacist counseling of
pregnant or lactating women. J Am
Pharm Assoc (Wash) 2001, 41: 887-
90.
USA.
Mail questionnaire sent in 1998-99
to 265 pharmacists practicing in
community pharmacies in Nebraska,
with adequate representation of
rural pharmacists by using a
stratified sampling technique. No
details were provided on how
potential participants’ details were
obtained. Repeat mailing was done
to all non-respondents using a
modified Dillman technique.
To provide a better understanding
of the role pharmacists play in
counselling pregnant or
breastfeeding women and to assess
pharmacists’ comfort level with
counselling these patients.
RR = 42% (110/265). Respondents reported counselling pregnant/breastfeeding
women an average of 2.8 times per week. Pharmacists rated themselves as both
qualified to make, and comfortable with making, therapeutic recommendations
for this patient group. Compared with pharmacists who had practiced for greater
than 30 years, those who had practiced for less than 30 years felt more qualified
and comfortable, and believed that pharmacy schools did not provide adequate
training, and therefore placed greater value on continuing education, in this area.
Pharmacists varied in their responses to whether they would recommend
medications for 7 common OTC-treatable conditions (cough, cold, analgesia,
constipation, diarrhoea, insomnia and heartburn) e.g. for cough, 55% said they
wouldn’t recommend any medications compared with only 38% who said the
same for conditions requiring analgesia. Some pharmacists also recommended
some medications that are unsafe in breastfeeding (e.g. 10% recommended
diphenhyramine for insomnia and 16% recommended dextrometorphan for
cough). Several commented about alternative, non-pharmacological treatments
they would prefer to recommend first for 6/7 of the conditions.
[23] Jones W, Brown D.
‡ The
medication vs breastfeeding
dilemma. Br J Midwifery 2003, 11(9):
550-55.
England.
See publication 22 in this table. As for publication 22 in this table. The figures reported in this publication differ slightly from those in publication 22,
despite being the same study, and this publication reports less than, but similar
results to, publication 22. Therefore, only new results are presented here. 80% of
GPs had personal/partner experience of breastfeeding, and comments made by
participants indicated that their experiences were different to those of the
pharmacists. 3% (19/641) of pharmacists said that they were never asked about
medication safety in breastfeeding by their customers, compared to 9% (60/641)
who reported being asked around once a week. Both GPs (76%, 450/589) and
pharmacists (81%, 522/641) thought it was difficult to stop breastfeeding abruptly
and made varying comments about providing information to breastfeeding
women on medication safety and use.
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(Continued)
[31] Long L, Montouris G.
Knowledge of women’s issues and
epilepsy (KOWIE-II): a survey of
health care professionals. Epilepsy
Behav 2005, 6(1):90-3.
USA.
Attendees of the American College
of Physicians 2003 annual meeting
invited to undertake a web-based
version of the KOWIE-II, a validated
and reliable tool for investigating
issues that affect women with
epilepsy, such as effects of
antiepileptic medicines on oral
contraception, bone health, sexual
function, pregnancy and
breastfeeding. Participants could
choose either ‘true’, ‘false’ or ‘don’t
know’ to each item.
To assess what physicians know
about issues pertaining to women
with epilepsy.
RR not calculated. 202 respondents completed the survey, the majority of whom
were physicians (92%). 4% were medical students and the remaining 2% were
other health professionals not named. Most respondents were male (66%) and
their mean age was 38 years. The majority (80%) treated less than 10 patients
with epilepsy per month. The most common specialty was internal medicine
(74%), followed by pulmonology (14%) and general practice (3%). In response to
the item, ‘Most women taking antiepileptic drugs can safely breastfeed’, only 47%
identified the correct answer (’true’), with 22% responding in the negative (’false’)
and 32% not knowing (’don’t know’).
[17] Amir LH, Pirotta MV.* Medicines
for breastfeeding women: a postal
survey of general practitioners in
Victoria. Med J Aust 2009, 191:126.
Australia.
Mail questionnaire sent in 2007-8 for
anonymous completion to 640 GPs
who provided shared maternity care
at the RWH in Melbourne, Victoria.
Repeat mailing was done to all
potential participants, and a
reminder postcard was sent in-
between the first and second
mailings. See publication 21 in this
table for information on how
potential participants were identified
in this study.
To describe GPs’ current and
preferred sources of information
about the safety of medications
during breastfeeding.
RR = 52% (335/640). Most respondents were women (70%, 233/333), and most
(68%, 227/333) had personal/partner experience of breastfeeding for longer than
6 months. 70% of GPs used the internet during consultations and 82% found it to
be helpful. Most (73%) obtained information about medications and
breastfeeding from their software prescribing program or from dedicated books
(61% predominantly used the RWH** reference text, Drugs and breastfeeding),
and 51% used telephone advice (predominantly from the RWH pharmacy).
However, some GPs wrongly assumed that the drug categories for pregnancy
also applied to breastfeeding women. Their software prescribing program and a
reliable internet database were preferred by respondents as information sources.
The need for an internet database was appealed for using the example of
ibuprofen - inconsistent recommendations in manufacturers’ product information
exist on its safety, and only 31% (102/330) of surveyed GPs were aware that it is
safe in breastfeeding even though most (89%, 293/331) were confident about
prescribing medications for breastfeeding women.
[32] McAuley JW, Casey J, Long L.
An evaluation of pharmacists’
knowledge of women’s issues in
epilepsy. Epilepsy Behav 2009, 14
(1):243-6.
USA.
A random sample of 500
pharmacists registered in Ohio were
sent a mail version of the KOWIE-II
questionnaire (see publication × in
this table for details of this tool), or
completed it prior to a live
continuing education seminar. The
year of survey distribution was not
given and participants’ preferences
for epilepsy education were not
determined either. Data for both
methods of administration was
pooled and analysed. The percent
correct score was calculated per
pharmacist.
To assess what pharmacists know
about issues pertaining to women
with epilepsy.
RR = 22% (109/500, mail survey). 43 surveys were completed at the continuing
education seminar. 45% of respondents were female, their mean age was 51
years, and most identified themselves as community pharmacists (79%).
Participants’ mean number of years spent in their current practice setting was 19
and the average number of patients with epilepsy seen per month was 14. 50%
of the respondents treated less than 10 patients with epilepsy per month. In
response to the item, ‘Most women taking antiepileptic drugs can safely
breastfeed’, only 34% identified the correct answer, with 36% responding in the
negative and 31% not knowing.
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(Continued)
[26] Ronai C, Taylor JS, Dugan E and
Feller E. The identifying and
counseling of breastfeeding women
by pharmacists. Breastfeed Med
2009, 4: 91-5.
USA.
Written questionnaire administered
at pharmacy sites by a student
researcher in 2007, to 36/47
pharmacists in Rhode Island (1
questionnaire per pharmacist per
site). This was preceded by
distribution of the reference text,
Medication and Mothers Milk (Hale)
to pharmacists by the Rhode Island
Department of Health in 2006,
following preliminary feedback from
a number of pharmacists that the
book was not available.
To determine what strategies and
resources pharmacists were using to
identify breastfeeding women and
guide medication recommendations.
RR = 92% (33/36). 58% of respondents never asked women if they were
breastfeeding and some were concerned that asking this question would cause
offense. 61% believed that women should self-disclose to the pharmacist that
they are breastfeeding, and one-third thought that the prescribing physician
should alert the pharmacy or that they could check by identifying if the woman
had received prenatal vitamins. Most pharmacists (85%) reported feeling
somewhat or very comfortable giving advice to breastfeeding women. Nearly half
(45%) reported receiving enquiries daily or weekly and used various resources to
guide their recommendations, most commonly the Physician’s Desk Reference,t h e
respective pharmacy chain’s intranet, and Medication and Mothers Milk. All but
one pharmacist who had received the latter reference reported using it at least
monthly.
[18] Amir LH, Pirotta MV.* Medicines
for breastfeeding women: a postal
survey of knowledge, attitudes and
practices of general practitioners in
Victoria, Australia. August 2010, La
Trobe University: Melbourne.
Australia.
See publication 17 in this table. To determine GPs’ attitudes to
breastfeeding; knowledge of one
medication that has a side effect of
reducing milk supply; advice for
breastfeeding women regarding
several medications (paracetamol,
ibuprofen, metronidazole, St John’s
wort and lithium); reports of adverse
events for infants; and most
preferred sources of information
about medications for breastfeeding
women.
See RR for publication 17. Over half of the GPs were generally supportive of
breastfeeding, disagreeing with unsupportive statements e.g. “In most cases a
breastfeeding mother must temporarily wean her baby while she is taking
prescription medications” (89%, 295/333). 64% (215/335) of respondents could
correctly name one medication that had a side effect of reducing milk supply;
however, 22% (75) skipped this question. Less than one third knew that ibuprofen
(30%, 102/335) and metronidazole (22%, 72/335) are compatible with
breastfeeding. Only 2% of GPs (6/333) knew that St John’s wort is relatively
compatible. Many (51%, 168/330) said they need to look into the use of lithium
(the infant needs to be monitored and breastfeeding is usually discontinued) or
that they have concerns about its use (42%, 140/330). Most knew (88%, 291/331)
that paracetamol is compatible. The majority of respondents (90%) drew on
previous clinical experience to make decisions around medication safety in
breastfeeding, with few (n = 6) having told women to stop breastfeeding during
therapy. Concern about medico-legal issues was common (76%, 250/330 rated it
as an ‘important/very important’ factor in decision-making for medicines for
breastfeeding women). Only 18% (61/335) were able to report an adverse event
associated with maternal use of medications whilst breastfeeding (where the
most commonly reported adverse event was associated with antibiotic use), and
none of the events were serious. GPs wanted practical information about
medications for breastfeeding women available via their software prescribing
program (68%) or a reliable internet database (57%).
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(Continued)
[21] Jayawickrama HS, Amir LH,
Pirotta MV. * GPs’ decision-making
when prescribing medicines for
breastfeeding women: Content
analysis of a survey. BMC Research
Notes 2010, 3:82. Australia.
See publication 17 in this table.
Additional detail about how
participants were identified was
given in this publication: a current
list of 666 GPs was obtained from
the RWH. However, details on how
640 of them were selected as
potential participants were not
provided.
Using content analysis, to determine
factors governing GPs’ decision-
making in response to a question
about prescribing medications for a
breastfeeding woman.
See RR for publication 17. The most common conditions for which GPs had last
had to decide about medication use for a breastfeeding woman were mastitis
(24%), other infections (24%) and depressive disorders (21%), where the decision
to use anti-infectives was reported to be easier than determining antidepressant
use. The 6 organising themes that emerged from 253 responses were: “certainty
around decision-making”, “uncertainty around decision making”, “need for drug
information to be available, consistent and reliable”, “joint decision-making”, “the
vulnerable third party”, and “infant feeding decision”. Certainty was associated
with positive feelings such as being happy, comfortable and confident, compared
to uncertainty that was associated with negative feelings such as concern and
doubt. Various sources were accessed by GPs for information on medication
safety in lactation, including pharmacists whose opinions sometimes clashed with
their own. The need for reliable and consistent information was noted, especially
on complementary medications. Involving the mother and other health
professionals in a joint decision-making process was felt to be necessary in
facilitating a safe outcome for the woman and increasing the chances of her
compliance with the recommended/prescribed medication. GPs undertook
“benefits versus risk” assessments when considering medication safety, however
didn’t consider the potential exposure to the infant (the “third party”). Some GPs
advised unnecessary cessation of breastfeeding during medication use and others
emphasised its continuance. “Complexity of managing risk in prescribing for
breastfeeding women” was identified as the global theme.
‡These two publications concern the same study and their results are similar, however publication 23 reports less results than publication 22.
**RWH = Royal Women’s Hospital
# These three publications report different aspects of the same study.
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6Table 2 Publications (in chronological order) on women’s knowledge, attitudes and practices towards medication use and safety in breastfeeding
Publication details and
country
Study design, participants and setting Study aims Key findings
[24] Matheson I, Kristensen K,
Lunde PKM. Drug utilization
in breast-feeding women: A
survey in Oslo. Eur J Clin
Pharmacol 1990, 38: 453-9.
Norway.
Questionnaire mailed to random sample of
20% (n = 1131) of women who gave birth
in Oslo in 1985. No details were provided
on how participants were selected for the
study and how their details were obtained;
however, readers are referred to a previous
publication (not in English) by the authors
for a more detailed description of the study.
To investigate the extent of and
predictors of medication use in
women during the first months after
birth, and to identify those
symptoms in women that led to
medication use during this time. The
general attitude to medications was
tested by asking about medication
taking behaviour when suffering
from a strong headache.
RR = 78% (885/1131). Fewer of those women who were breastfeeding at 4
months after birth (n = 645) were using medications than those who had
stopped breastfeeding before 4 months (n = 240). The average number of doses
was 166 and 307 respectively in that period. The number of doses was
significantly associated with the use of oral contraceptive agents (p < 0.005) and
young maternal age (p < 0.05). Most commonly reported conditions for which
medications had been used in the 4 month period were dyspepsia,
haemorrhoids, mastitis, rash/eczema, cracked nipples, headache, allergy and
constipation. Analgesics/antipyretics (31%), dermatologicals (19%) and
haemorrhoidals (15%) were most commonly taken at least once during the 4
months after birth, and vitamins and iron preparations were taken more
frequently by those still breastfeeding. Long-term medication in breastfeeding
women included many medications for which there was incomplete or no data
about safety at the time of the study (e.g. cromoglycate, topical corticosteroids,
salbutamol, insulin and thyroxine). 35% of breastfeeding women smoked daily, as
did 65% of those not breastfeeding at 4 months, and there was no difference
between breastfeeding and not breastfeeding women with regards to abstinence
from alcohol (17 and 16%), but significantly more of those non breastfeeding
were abstainers from coffee. 36% of women had less, 33% had similar, and 17%
had more doubts about medication use during lactation than in pregnancy. 13%
could not assess the perceived risk of medication use during lactation in relation
to that in pregnancy. An association between the number of medications per
woman and doubts about medication use during breastfeeding was found (p <
0.001).
[20] Ito S, Koren G, Einarson
TR. Maternal noncompliance
with antibiotics during
breastfeeding. Ann
Pharmacother 1993, 27: 40-2.
Canada.
Prospective cohort study by telephone
follow-up of 203 breastfeeding women who
were prescribed antibiotics as monotherapy
and consulted the Motherisk Program
between January 1990 and July 1991.
Telephone interviews were conducted by
Motherisk counsellors or trained toxicology
students. The program was a consultation
and follow-up service at a tertiary care,
paediatric hospital in Toronto, for healthcare
professionals and women with concerns
about exposure to medications, chemicals
and radiation during pregnancy and
breastfeeding.
To determine the incidence of
antibiotic prescription failure in
breastfeeding women, and to
characterise breastfeeding patterns
during antibiotic therapy.
62% (125/203) of breastfeeding women who consulted the Motherisk Program
for information about the safety of antibiotics during breastfeeding were
followed up within 32 weeks. 15% (19/125) of these women did not initiate
therapy and Category* A antibiotics (e.g. metronidazole, chloramphenicol,
tetracycline, doxycycline) were associated with the highest rate of non-use in this
group of women, all of whom continued breastfeeding during the treatment
period. 7% of the remaining 106 women who started taking a prescribed
antibiotic stopped breastfeeding during therapy. In this group of women,
Category A and B (e.g. norfloxacin, ciprofloxacin, spiramycin) antibiotics were
associated with a significantly higher incidence of breastfeeding interruption (p <
0.01) than those in Category C (e.g. penicillins and cephalosporins). This means
that 21% of women (26/125) eventually avoided exposing their infant to the
medication. Despite reassuring advice from the program’s staff (based on data
from available texts, the recommendations of the American Academy of
Pediatrics, case reports, and the authors’ own experience), it was estimated that 1
in 5 women did not initiate therapy or did not continue breastfeeding.
[25] Merlob P, Bracha S,
Kaplan B. Drug use in
pregnancy and breast
feeding: the role of the
pharmacist. The International
Journal of Risk and Safety in
Medicine 1998, 11: 45-7
Israel.
204 women interviewed by a neonatologist
(specially trained in teratology) at discharge
from a maternity ward (assumed to be
located at Rabin Medical Center), two to
three days after delivery. No details were
provided on how participants were selected
for the study.
To examine the rate of pharmacist
counselling of women who use
medications during pregnancy and/
or breastfeeding.
63% (129/204) of women reported that they were counselled by their physician,
compared with 9% (18/204) who indicated that they were counselled by the
pharmacist. 8% (16/204) of women had read the information leaflet
accompanying the medication and in many instances, no leaflet was provided
at all.
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6Table 2 Publications (in chronological order) on women?’?s knowledge, attitudes and practices towards medication use and safety in breastfeeding
(Continued)
[22] Jones W, Brown D
‡. The
pharmacist’s contribution to
primary care support for
lactating mothers requiring
medication. Journal of Social
and Administrative Pharmacy
2000, 17: 88-98.
England.
Mail questionnaire sent to 967
breastfeeding women in the South and
West NHS Executive region of Hampshire,
Wiltshire, Dorset and the Isle of Wight. The
women were not a random sample of the
study area population as they were
systematically selected from the National
Childbirth Trust and on a proportional basis
to represent all of its branches across the
geographical area.
To assess what information mothers
were given or wished to be given
on medication safety and whether
professionals provided this.
RR = 85% (820/967 women). 57% of women reported taking medication after
birth, but just over half of the women (51%) recollected being asked if they were
breastfeeding. 42% did not recall receiving any medication after birth. The
majority of women (279) who were prescribed medication (mostly analgesics and
oral contraceptives) recalled being asked by their GP if they were breastfeeding,
29% (131) stated they were not asked, and 30 did not remind their GP that they
were breastfeeding. 54% of women said they had bought OTC medications from
a pharmacy but only 11% recalled being asked if they were breastfeeding, and of
the 82% who said they weren’t asked, 34% reminded the pharmacist that they
were breastfeeding. 28% were satisfied with the advice given by GPs and
pharmacists and 31% felt dissatisfied with the quality of information given. 6%
said that they received conflicting advice. 48 women were advised to
discontinue breastfeeding, 28 refused the medication, 25 requested an alternative
medication, 24 expressed breast milk temporarily, 17 discontinued breastfeeding
and 10 sought a second opinion.
[23] Jones W, Brown D
‡. The
medication vs breastfeeding
dilemma. Br J Midwifery
2003, 11(9): 550-55.
England.
See publication 22 in this table. As for publication 22 in this table. The figures reported in this publication differ slightly from those in publication
22, despite being the same study. Therefore, only new results are presented here.
48% (395/820) of women continued to breastfeed at 6 months and 19% (153/
820) were breastfeeding at the time of completion of the questionnaire. While
250 of the medications taken by women after birth were analgesics and 63 were
antibiotics, a wide range of other medication was given, such as antiepileptics,
antihypertensives, antihistamines and thyroxine. Similarly, the majority of
prescriptions received from GPs once women were home were for antibiotics
and analgesics, but also included antidepressants and iron supplements.
[30] Lee A, Moretti ME,
Collantes A, Chong, D,
Mazzotta P, Koren G,
Merchant SS, Ito S. Choice of
breastfeeding and physicians’
advice: A cohort study of
women receiving
propylthiouracil. Pediatrics
2000, 106(1):27-30.
Canada.
Prospective cohort, observational study. 78
women who contacted the Motherisk
program between 1990-97 to enquire about
foetal safety of PTU therapy were
interviewed postpartum regarding their
choice of infant feeding method and
relevant advice received from physicians.
Women who rang the program to
determine its safety in breastfeeding were
excluded from the study. Data for 3 groups
of women were compared: group 1)
women who required PTU postpartum;
group 2) women who no longer required
the medicine; and group 3) a control group
of age-matched women who contacted the
program within the same year as their
counterparts and who were not taking any
chronic medicines or teratogenic or toxic
substances.
To determine whether there is a
relationship between physicians’
advice and women’s initiation of
breastfeeding during PTU therapy, as
well as the extent of physician
compliance with evidence-based
data on the safety of this medicine
in breastfeeding.
66/78 women identified had live births and were included in the study. 55% (36/
66) of women were in group 1, 46% (30/66) in group 2, and 36 in group 3.
Breastfeeding initiation rates for these groups were 44%, 83% and 83%
respectively (group 1 vs group 2, p < 0.01; group 1 vs group 3, p < 0.01),
however, demographic characteristics of the 3 groups were similar. In group 1,
10/36 women did not seek advice from physicians and the remaining 26 (72%)
received advice from 39 physicians. 62% (24/39) of physicians advised women to
breastfeed, 33% (13/29) advised not to breastfeed and 5% (2/29) gave equivocal
advice. Of 18 women who received advice in favour of breastfeeding by at least
1 physician, 83% (15/18) initiated breastfeeding. Whereas of the 8/24 women
who did not receive advice in favour of breastfeeding, none breastfed. 60% (12/
20) of women who chose to formula feed indicated physicians’ advice against
breastfeeding or their concern about the medicine as the main reason for not
breastfeeding. 50 women who breastfed received advice from 22 physicians
regarding breastfeeding (20 in favour, 1 against and 1 equivocal), and 11 who
formula fed received advice from 17 physicians (4 in favour, 12 against and 1
equivocal). Physicians’ advice was the only significant predictor of the woman’s
choice to breastfeed during PTU treatment (relative risk: 5, 95% CI: 1-23).
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6Table 2 Publications (in chronological order) on women?’?s knowledge, attitudes and practices towards medication use and safety in breastfeeding
(Continued)
[27] Schirm E,
Schwagermann MP, Tobi H,
de Jong-van den Berg LT.
Drug use during
breastfeeding. A survey from
the Netherlands. Eur J Clin
Nutr 2004, 58: 386-90.
Netherlands.
Questionnaire given to all women (for
completion at home) with a child not older
than 6 months, who had visited a Well-Baby
Clinic in the province of Friesland. If the
woman visited the clinic more than once in
the study period, only one questionnaire
was handed out, and if someone other
than the woman came to the clinic with
the child, they were asked to pass on the
questionnaire to the woman. This was
carried out over a 6-week period in
November-December 2002 across 85 Clinics.
To survey medication use by
breastfeeding women, and to
compare this with non-breastfeeding
women. Also to explore whether
medication use influenced women’s
decisions to breastfeed and vice-
versa.
RR ≈ 43% (549 returned questionnaires). 82% of respondents breastfed their baby
some time during the first 6 months after birth. 66% of all breastfeeding women
had used medications, but less frequently than non-breastfeeding women (80%).
Vitamins were used more frequently by breastfeeding women, whereas oral
contraceptives, iron preparations, and peptic ulcer and psychotropic medications
use was higher in non-breastfeeding women. 30% of women hesitated to use
medications during breastfeeding, 10% stopped either breastfeeding or
medication use to avoid combining the two, 5% took a measure to minimise
exposure to the child, and 12% did not breastfeed because of medication use.
[19] Boath E, Bradley E,
Henshaw. Women’s views of
antidepressants in the
treatment of postnatal
depression. J Psychosom
Obstet Gynecol 2004, 25:
221-33.
UK.
Questionnaire administered to 35 women,
in their homes, who had a baby aged
between 6 weeks and 1 year and who
either scored above 12 on the Edinburgh
Postnatal Depression Scale or were
diagnosed with clinical depression by a
psychiatrist. Women were participating in a
wider study (that the authors have
referenced and provides more information
on how participants were identified and
selected for the study) of the cost-
effectiveness of services for PND.
To determine the experiences of
postnatally depressed women with
regards to antidepressant treatment.
RR = 43% (60/82 women fulfilled the recruitment criteria, however, only 35 were
taking antidepressant medication - 5 were on SSRIs**, 25 were prescribed TCAs
#,
2 of these were subsequently prescribed SSRIs and 3 were subsequently
prescribed flupenthixol. One woman was taking flupenthixol alone). All women
were of white ethnicity. 13/35 women were breastfeeding and 4/13 (31%) did
not want to take the antidepressant for that reason. It was also reported that the
literature shows that TCAs and SSRIs are safe for infants, but should be prescribed
only after the risk-benefit ratio is clearly outlined and discussed with the woman
and her partner.
[29] Turner K, Sharp D,
Folkes, Chew-Graham,
Women’s views of
antidepressants as a
treatment for postnatal
depression: a qualitative
study. Fam Pract 2008,
25:450-55.
UK.
In-depth interviews between November
2006-June 2007 with 27 women in three UK
cities, at their homes or over the telephone.
Women had been diagnosed with postnatal
depression and taken part in a randomised
controlled trial (that the authors referenced
and provides more information on how
participants were identified and selected for
the study), involving antidepressants versus
antidepressants and non-directive
counselling. A purposeful sampling
approach was used to ensure interviews
were held with women randomised to
different treatment arms and living in
different cities.
To determine the experiences and
views of postnatally depressed
women with regards to
antidepressant treatment.
Women expressed concerns about taking antidepressants when breastfeeding,
however the associated medications were not reported and comments to
illustrate these concerns were also not provided. Moreover, the number of
women who were breastfeeding was not given. It is not known whether women
specifically discussed with their GP the issue of using antidepressants when
breastfeeding. Most women were of white ethnicity (21/27).
*Categories were defined as A = relatively incompatible with breastfeeding; B = probably compatible; and C = safe to use in breastfeeding.
‡These two publications concern the same study and their results are similar, however, publication 23 reports less results than publication 22.
**SSRIs = serotonin selective reuptake inhibitors
#TCAs = Tricyclic antidepressants
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6contain ethanol) for breastfeeding women [28]. In other
studies, only 34% of pharmacists [32] and 47% of physi-
cians [31] knew that most women taking antiepileptic
medicines can safely breastfeed; 66% of pharmacists and
54% of physicians thought they were unsafe or were
unsure about their safety.
Similarly, in the study by Schrempp, Ryan-Haddad and
Gait, some pharmacists recommended alternative, non
pharmacologic treatments first, such as bran cereal or
prune juice as natural laxatives for constipation; saline
nasal drops, cool mist vaporiser or echinacea for colds;
and dietary limitations, including eating smaller meals,
for heartburn [28]. While such recommendations are
safe, reasonable and are usually trialled before prescrib-
ing medications, they work best in conjunction with
pharmacological measures and may only provide tem-
porary relief of the breastfeeding woman’s symptoms. In
addition, pharmacists in this study who had practiced
for less than 30 years more highly valued continuing
education (CE) on medication safety and use in breast-
feeding than pharmacists who had practiced for more
than 30 years [28], but were either not asked, or did not
indicate, their preference(s) for formats of CE.
Poor knowledge of medication use in breastfeeding may
also extend to inadequate medical history-taking skills,
where important information is not gleaned from the
breastfeeding woman by the health professional. Ronai
et al found that 58% of pharmacists surveyed never asked
w o m e ni ft h e yw e r eb r e a s t f e e ding [26]; however, this
study was carried out with a small sample of participants.
While Jones and Brown reported that 50% of pharmacists
s a i dt h e yw o u l da s kaw o m a nw i t hab a b yh o ws h ew a s
feeding before prescribing an over-the-counter (OTC)
medication (available without prescription) for her, many
pharmacists stated that it was the responsibility of the
woman to inform them that she was breastfeeding when
purchasing a medication, with two pharmacists com-
menting that questions of this nature are too personal
and cannot be asked in the pharmacy environment [23].
In the same study, only 22% of GPs surveyed said that
they would ask the mother of a ‘toddler’ (taken to be
older than 12 months) if she was breastfeeding before
prescribing medication for her [22,23]. This is concern-
ing, given that women may continue to breastfeed after
their child turns 12 months old - the minimum age
recommended in Australia [34] - meaning that both
GPs and pharmacists may not be considering that
mothers of children who are no longer newborn may be
breastfeeding. Individual comments provided by GPs
and pharmacists in the study by Jones and Brown “gave
an impression of ambivalence to breastfeeding, particu-
larly as the child got older and that they would advocate
artificial milk formula as a substitute” [22].
This attitude, as seen from the woman’s perspective, is
reflected in the comment below, made by a mother in
the study by Jones and Brown [23]. Indeed, the World
Health Organization (WHO) and United Nations Inter-
national Children’s Emergency Fund (UNICEF) recom-
mend exclusive breastfeeding for six months, with
introduction of nutritionally adequate, safe and appro-
priate complementary foods (to prevent iron deficiency)
and continued breastfeeding thereafter.
Table 3 Publications on recommendations made by resources on medication use and safety in breastfeeding
Publication details and country Study design and setting Study aims Key findings
[16] Akus M, Bartick M. Lactation
safety recommendations and
reliability compared in 10
medication resources. Ann
Pharmacother 2007, 41: 1352-60.
USA.
10 frequently used sources of
information (see Table 4) by US
health professionals on medication
safety in lactation were evaluated
and compared with each other, for
14 commonly used medications
(acyclovir, amlodipine, ampicillin,
ciprofloxacin, enalapril, haloperidol,
metformin, methotrexate,
metoprolol, pantoprazole,
paroxetine, sertraline) widely
recognised as safe, not safe or
neither. The number of medications
thought to be safe for each source
was also assessed.
To determine the reliability of
safety recommendations for
medications used during lactation,
based on current research and
information. Also to determine
whether resources may be
inappropriately advising the
interruption of breastfeeding.
Medication and Mothers Milk and
LactMed had the highest number
of safe-rated medications (12/14
and 11.5/14 respectively) among
the sources used, compared with
the 2 retail pharmacy databases,
Lexi-Comp and the Physician’s Desk
Reference, which listed the fewest
number of safe medications (0.5/14
and 0/14 respectively) and lacked
safe listings even for those widely
accepted as safe. Of all sources
across the sample of 14
medications, LactMed more
consistently contained more
extensive and current citations,
suggesting that it may have been
the most reliable source at the time
of the study. For medications
thought to be unsafe, the 2 retail
pharmacy databases gave an
alternative recommendation 75% of
the time.
Hussainy and Dermele International Breastfeeding Journal 2011, 6:11
http://www.internationalbreastfeedingjournal.com/content/6/1/11
Page 11 of 16“In my experience, the medical profession do not
expect breastfeeding beyond 9 to 12 months. Beyond
that they never ask if you are feeding and act sur-
prised when you point it out” [23] (p. 553).
On the other hand, some GPs practicing in Australia
have been reported to feel confident about medication
use in breastfeeding women [18]. However, despite their
self-reported confidence, in a postal survey of GPs in
Victoria, respondents had concerns about medico-legal
issues: 76% of GPs rated the possible risk of litigation as
“important/very important” [18]. Similarly, it has been
found that some pharmacists feel comfortable advising
breastfeeding women and are cautious with their recom-
mendations to them [26]. In this study by Ronai et al,
pharmacists believed that it is better to stop breastfeed-
ing than risk exposing an infant to a potentially harmful
medication [26]. They also commented that there are
contradictory and inconsistent resources available on
medication use in lactation, as have GPs who have also
indicated the need for a reliable internet database (that
includes information on complementary medicines), or
information via their software prescribing program,
[17,18,21] instead of having to rely on pharmaceutical
Table 4 List of resources, type and utility (in alphabetical order) on medication safety in breastfeeding that have been
previously investigated by Akus and Bartick [16]
Name of resource Type of resource Utility of resource
American Academy of Pediatrics
(AAP) list
Online http://pediatrics.
aappublications.org/content/108/3/
776.full.html
This list is reviewed by an expert panel who applies a descriptive rating
system. Possible effects of agents (medicines and other treatments or
products e.g. silicone implants, nicotine) on the infant or on lactation are
described in tabular format. The intention is to help physicians with
counselling a nursing mother regarding breastfeeding when the mother
has a condition for which a medicine is indicated.
Clin-eguide
http://www.ovid.com/site/
products/tools/ovid/
ClinicalResource.jsp
Patient handout from pharmacy
database
Clin-eguide is an Ovid Clinical Decision Support tool for physicians. In this
study, it was used by a retail pharmacy to provide information on the use
of medicines in breastfeeding in the form of patient handouts (MedFacts).
Drugs in Pregnancy and
Lactation
Book Consists of monographs that include primary research and the AAP rating,
as well as its own descriptive rating system.
Epocrates Web-based http://www.epocrates.
com/ and handheld
Program used by pharmacists and prescribers that provides a brief
recommendation for each medicine, such as ‘safe’ or ‘unknown’ without
additional information. The source of the recommendation is not given.
First DataBank
http://www.firstdatabank.com/
Patient handout from pharmacy
database
Similar to Clin-eguide, this is a clinical decision support tool that provides
access to drug databases. In this study, it was used by a retail pharmacy to
provide information on the use of medicines in breastfeeding in the form
of patient handouts.
LactMed Online http://toxnet.nlm.nih.gov/
cgi-bin/sis/htmlgen?LACT
Free online resource from the National Library of Medicine that has been
assembled by an expert panel. Features drug monographs and typically
includes primary research, the AAP rating, and a summary at the top of
each monograph. Unlike the AAP list and Drugs in Pregnancy and Lactation,
it does not have a descriptive rating system. Among the data included are
maternal and infant levels of drugs, possible effects on breastfed infants
and on lactation, and alternate medicines to consider.
Lexi-Comp Web-based http://www.lexi.com/
and handheld
Program used by pharmacists and prescribers (e.g. physicians, advanced
practice nurses, dentists) that gives brief recommendations on lactation and
breastfeeding considerations which are sometimes not consistent with each
other. It often cites the AAP list but does not typically elaborate on its
conclusions otherwise.
Medication and Mothers Milk Book Written by a clinical pharmacologist (Hale, Thomas) and updated biannually,
this book features monographs on a large range of medicines (e.g. vitamins,
herbs, vaccines) and environmental substances (e.g. radioisotopes,
radiocontrast agents). Relevant pharmacological characteristics, primary
research, and the AAP ratings are included in the monographs. Rather than
a descriptive rating system, it applies a 5 point numerical rating system to
each medicine, where L1 is safest and L5 is contraindicated.
Micromedex Online http://www.micromedex.
com/ and handheld
Used by pharmacists and other clinicians and similar to Clin e-guide and
First Databank, this is a clinical decision support tool that consists of
monographs that include primary research and the AAP rating. It also
features its own descriptive rating system.
Physician’s Desk Reference
http://www.pdr.net/
Pharmacy database Like Clin e-guide and First Databank, this program can be used to generate
package inserts or patient handouts on the use of medicines in
breastfeeding. It gives little information on how its recommendations were
reached.
Hussainy and Dermele International Breastfeeding Journal 2011, 6:11
http://www.internationalbreastfeedingjournal.com/content/6/1/11
Page 12 of 16companies for drug information that is usually “over
cautious” [21].
In this Victorian survey with GPs, several participants
reported that advice their patients had received from
community pharmacists sometimes conflicted with their
own decisions, unnecessarily resulting in patient alarm
[21]. Community pharmacists in these scenarios had
questioned GPs’ decisions to prescribe fluconazole or
metronidazole. It was also found that some GPs were
referring to pharmacists at the Royal Women’sH o s p i t a l
(RWH), and held these pharmacists, or others working
elsewhere, in high esteem:
“The pharmacist at RWH [is] excellent - gives var-
ious sources of information and good opinion re:
overall management ...”[21] (p. 5).
“Depression. Efexor [venlafaxine]. Checked with Box
Hill Hospital pharmacist via phone. Got the most
reliable and up to date info ...” [21] (p. 5).
If pharmacists, particularly those working in commu-
nity settings, have insufficient knowledge and they are
providing information to patients that ‘challenge’ GPs’
decisions, this is a dilemma. If pharmacists continue
providing inconsistent information and if their knowl-
edge gaps are not met, they could potentially discredit
themselves as medicine experts. Also, as some informa-
tion provided by pharmacists is based on “personal deci-
sion”, as demonstrated in the comment below by a
participant in the aforementioned study [21], it could
potentially be harmful to women.
“Depression. Most information is ‘personal decision’
i.e. no good evidence. Reasons for decision - local psy-
chiatrist opinion, RWH pharmacist’s opinion ...” [21]
(p. 5).
These findings from the Victorian survey [17,18,21]
should be considered in the context of having an unre-
presentative sample. The invited sample had more
female GPs than males (because more females in Aus-
tralia are involved in shared maternity care than male
GPs), the proportion of female to male respondents is
higher than in the invited sample, and those who did
respond probably had a greater interest in the topic
than non-responders. Taken altogether, it is highly likely
that the results in this survey underestimate the true
situation.
Breastfeeding women
No studies were uncovered in 2006 and between 2009-
10 on women’s knowledge, attitudes and practices
towards medication use and safety in lactation. Most of
the limited studies undertaken with breastfeeding
women from 1990-2008 show that some were inappro-
priately advised by a health professional to unnecessarily
cease or not even commence breastfeeding during the
pharmacotherapy [20,22,23,30], and if they hadn’t
received advice, they still had the same doubts or were
more reluctant to take medications during breastfeeding
than during pregnancy [24]. Some of these findings,
however, may not be relevant anymore as the work was
undertaken up to 20 years ago [20,24], and the study
with women from Oslo did not have adequate represen-
tation, with a lower response rate from women living in
high socioeconomic conditions than those from lower
socioeconomic environments [24]. Other work [19,29],
which includes one study that was recently conducted
[29], is also exclusively or mostly limited to women of
white ethnicity.
Regardless of these limitations, a proportion of women
in some of the studies consequently stopped either
breastfeeding or medication use to avoid combining the
two [20,22,23,27] or did not breastfeed at all [30], and
others took a measure to minimise exposure to the child
(e.g. expressing breast milk beforehand, breastfeeding
just before medication intake) [27]. However, due to dis-
satisfaction with the advice they received, some women
either did not commence the medication that was pre-
scribed for them or did not stop breastfeeding [20,22,23].
In the study by Jones and Brown, it was found that
only 28% of breastfeeding women were satisfied with
the advice given by their GP and pharmacist, compared
to 31% who were dissatisfied [22,23]. Moreover, 6% of
women said they received conflicting advice, and of the
54% of women who had bought OTC medications in a
pharmacy, only 11% were asked if they were breastfeed-
ing by the pharmacist or pharmacy assistant [22,23].
This study, however, involved women with a high socio-
economic status and education level who were likely to
breastfeed for longer, and their responses may not
represent the wider population [22,23]. Further, the sur-
vey instrument developed in this study did not have the
option of “Don’t know” or “Can’t remember” in order to
counteract potential memory recall bias [22]. Similarly,
in the study by Merlob, Stahl and Kaplan, only 9% of
women interviewed on discharge from the maternity
ward were counselled by the hospital/private pharmacist
and always at woman’s initiative; a lesser proportion
(8%) had read the information leaflet accompanying the
medication [25].
This is concerning, as pharmacists are responsible for
providing accurate medication-related advice and infor-
mation to the community, and it is their duty of care to
check, during this process, if a woman is breastfeeding
or pregnant if she is of childbearing age. It is also unsafe
for pharmacists and other health professionals to
assume that breastfeeding women are not likely to
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that 66% of all breastfeeding women had used medica-
tions; albeit less frequently than non-breastfeeding
women (80%) [27].
Resources on medication safety in breastfeeding
In the only study that has been conducted to assess
resources on medication safety in breastfeeding [16]
(Table 3), ten different resources available to health pro-
fessionals in the USA were investigated (Table 4) to
evaluate 14 medications used to treat conditions such as
bacterial and viral infections, hypertension, Type 2 dia-
betes mellitus and depression. Certainly, such resources
are widely used by physicians, but less so by specialists
such as endocrinologists, who prefer to conduct litera-
ture searches when unsure of the compatibility of a
medicine with breastfeeding [30].
The advantages and disadvantages of each resource
were described by Akus and Bartick, who concluded
that recommendations on the safety of all of the medi-
cations in breastfeeding varied considerably, and were
not based on the most recent research [16]. Two of the
sources appraised were databases used in two commu-
nity pharmacy chains - Lexi-Comp and the Physician’s
Desk Reference - that gave an alternative recommenda-
tion for medications thought to be safe at least 75% of
the time [16]. Furthermore, these databases usually
recommended early cessation of breastfeeding.
Certainly, the lack of, and inconsistency between, such
information, could be an underlying and determining
factor for the poor knowledge and variable practices dis-
played by health professionals towards medication use
in breastfeeding women.
Conclusions
Even though all the studies reported that there is a lack
of information on medication safety in breastfeeding for
health professionals [28], and the information available is
inconsistent [16,17,26], in the Victorian study, most GPs
were confident about medication use in breastfeeding
women [18], and in the Rhode Island study, most phar-
macists felt comfortable advising breastfeeding women
[26]. This mismatch between available information, and
comfort and confidence, needs to be further explored in
future research. It is possible that some health profes-
sionals who have personally experienced breastfeeding
have better knowledge and therefore comfort and confi-
dence, leading to more appropriate decisions regarding
breastfeeding and medication issues. However, “personal
experiences cannot necessarily be generalised to patients
and should not be relied upon” [1] (p. 28).
The lack of a uniformly accepted source of informa-
tion leads to conflicting advice which can have harmful
consequences for women [16]. This can also result in
public distrust, discontent [22], and loss of faith towards
health professionals, particularly pharmacists, who are
responsible for providing medication advice, and may
ultimately lead to breastfeeding women seeking advice
from people who are inappropriately qualified.
Further research is required to determine whether this
situation is currently occurring, as well as to scope, to a
greater extent, what the educational needs of women
from a range of ethnic and socioeconomic backgrounds
are with respect to medication use in breastfeeding. In
particular, in-depth studies are required to understand
the views of women who are considering taking medi-
cines which are regarded as risky, such as antidepres-
sants [19,29]. Similarly, women’s views about the use of
other substances by breastfeeding women, such as
tobacco, alcohol and caffeine, as well as illicit drugs,
needs to be looked into.
At this stage however, as a result of the inconsistent
information available for all stakeholders, pharmacists
and other health professionals seem to be relying on
their own personal experience (or a lack of it), resulting
in variable practices that may mean recommending the
cessation of breastfeeding and thus being overly cautious.
Consequently, the infant would be deprived of the bene-
fits that breast milk confers on growth, development,
health and nutrition. Women who stop breastfeeding
may perceive themselves as not being a ‘good mother’
which can negatively affect their self-esteem.
However, even if consistent and better quality infor-
mation did become available, health professionals need
to be rigorously trained on communicating with breast-
feeding women via the identification, through further
educational research, of continuing education formats
they prefer e.g. didactic or flexible delivery methods
such as online education programs. Indeed, in the study
by Jones and Brown, GPs and pharmacists indicated
that they would prefer a distance learning package on
this topic, whereas pharmacists were more enthusiastic
about interprofessional workshops [22]; however, this
work was done 10 years ago. More recently, Long and
Montouris reported that physicians preferred web-based
or didactic material [31], but a more in-depth investiga-
tion in to health professionals’ current educational
needs in this area is required.
Health professionals also need to actively seek infor-
mation about the breastfeeding status of women, then
consider the risk of damage from the medications and
the effects of the illness itself, as well as the risks of not
breastfeeding, on both the woman and the baby prior to
prescribing. Finally, health professionals have an obliga-
tion to extensively and adequately inform breastfeeding
women about the safety of medications and their possi-
ble side effects, and to provide alternative options in cir-
cumstances where medications cannot be used, or if the
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women are satisfied with the advice given to them.
The limited literature available indicates that health pro-
fessionals have poor knowledge, as well as positive atti-
tudes and variable practices that are mostly guided by
personal experience, towards medication use in breast-
feeding women. In turn, women are left dissatisfied with
the advice provided by health professionals. Further
research is needed to investigate this phenomenon.
Resources available for health professionals on medication
safety in lactation also need to be reviewed and updated to
remove inconsistencies and reflect recent evidence as well
as the experiences of expert practitioners in this area.
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